GET THE APP

Tissue Bulking Agent-Polyacrylate Polyalcohol Copolymer for Endoscopic Correction of Vesicoureteral Reflux in Children: A Comparative Study | Abstract
Medical & Surgical Urology

Medical & Surgical Urology
Open Access

ISSN: 2168-9857

Abstract

Tissue Bulking Agent-Polyacrylate Polyalcohol Copolymer for Endoscopic Correction of Vesicoureteral Reflux in Children: A Comparative Study

Michael E Chua, Jonathan S Mendoza, Odina R Gomez, Jan Michael Silangcruz, Christopher L Pineda, Jun S Dy and Marcelino L Morales Jr

Objective: To evaluate the treatment outcome of single session endoscopic treatment using Polyacrylate Polyalcohol Copolymer (PPC) (Vantris ®) compared with conservative Continuous Antibiotic Prophylaxis (CAP) and open surgical treatment among children with Vesico-Ureteral Reflux (VUR).

Methods: A retrospective cohort was undertaken in a single institution to evaluate children diagnosed with primary VUR grade 2-4 from 2006-2012 treated by a single urologist with different treatment modalities- conservative continuous antibiotic prophylaxis, endoscopic correction with PPC and open ureteral re-implantation with Cohen technique. Included patients for the study were only those who had 1-3 months and >1 year post-treatment follow- up study with Voiding Cystourethrogram (VCUG), kidney ultrasound, Dimercaptosuccinic Acid (DMSA) renal scan, and urine culture. Comparative analysis was made to evaluate the rate of VUR resolution, reflux recurrence, renal scaring and VUR treatment related hospital stay.

Results: Twenty-five children (12 girl and 13 boys) with a mean age of 3 ± 1.4 years were included. Twelve children had bilateral VUR and thirteen had unilateral VUR, a total of thirty-seven Refluxing Renal Units (RRU) were being analyzed (12 CAP, 11 endoscopic corrections and 14 open re-implantation surgery). On initial 3 months post-treatment follow-up, RRU VUR resolution observed for CAP, PPC and open surgery were 33% (4/12), 91% (10/11) and 100% (14/14), respectively. At >1 year post treatment follow-up, VUR resolution were noted in 50% (6/12) treated with CAP. For PPC treated group, 27% (3/11) had reflux recurrence or persistence and 14% (2/14) of open surgery group had ureteral obstruction with hydronephrosis. Renal scarring detected among CAP, PPC and surgery group at >1 year follow-up were 42% (5/12), 18% (2/11) and 14% (2/14), respectively. VUR treatment related mean hospital day per year was highest among the CAP group (6.25 ± 2.6 days/year) and lowest among PPC group (3.27 ± 1.2 days/year).

Conclusion: Endoscopic correction of VUR with PPC resulted to better treatment outcome when compared to CAP and was comparable to open surgical management with shorter treatment related hospital stay.